News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
487,774 Results
Type
Article (8332)
Company Profile (142)
Press Release (479299)
Multimedia
Podcasts (9)
Webinars (6)
Section
Business (167326)
Career Advice (314)
Deals (25842)
Drug Delivery (12)
Drug Development (53189)
Employer Resources (14)
FDA (9817)
Job Trends (8633)
News (239113)
Policy (17975)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (501)
Accelerated approval (25)
ADA (18)
Adcomms (1)
Allergies (97)
Alliances (33348)
ALS (106)
Alzheimer's disease (1003)
Antibody-drug conjugate (ADC) (294)
Approvals (10448)
Artificial intelligence (336)
ASCO (173)
Autoimmune disease (215)
Automation (28)
Bankruptcy (264)
Belgium (1)
Best Places to Work (7012)
BIO (36)
Biologics (6)
BIOSECURE Act (1)
Biosimilars (114)
BioSpace Insights (20)
Biotechnology (90)
Bladder cancer (139)
Brain cancer (37)
Breast cancer (524)
Cancer (3871)
Cardiovascular disease (229)
Career advice (254)
Career pathing (1)
CAR-T (179)
CDMO (17)
Celiac Disease (1)
Cell therapy (493)
Cervical cancer (35)
Clinical research (48303)
Collaboration (1309)
Commercialization (3)
Compensation (1523)
Complete response letters (37)
COVID-19 (770)
CRISPR (64)
C-suite (802)
Cystic fibrosis (86)
Data (5877)
Denatured (4)
Depression (104)
Dermatology (66)
Diabetes (351)
Diagnostics (4245)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (162)
Drug pricing (9)
Drug shortages (2)
Duchenne muscular dystrophy (180)
Earnings (73855)
Editorial (5)
Employer branding (2)
Employer resources (15)
Events (88304)
Executive appointments (716)
FDA (12553)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (961)
Gene editing (127)
Generative AI (11)
Gene therapy (340)
GLP-1 (302)
Government (965)
Grass and pollen (2)
Guidances (287)
Healthcare (9434)
Hematology (95)
HIV (53)
Huntington's disease (22)
IgA nephropathy (65)
Immunology and inflammation (105)
Immuno-oncology (61)
Indications (159)
Infectious disease (961)
Inflammatory bowel disease (128)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (260)
Interviews (44)
IPO (12413)
IRA (2)
Job creations (1973)
Job search strategy (239)
JPM (5)
Kidney cancer (21)
Labor market (4)
Layoffs (62)
Leadership (2)
Legal (5212)
Licensing (16)
Liver cancer (46)
Longevity (19)
Lung cancer (519)
Lymphoma (256)
Machine learning (29)
Management (3)
Manufacturing (591)
Marketing (8)
MASH (119)
Medical affairs (2)
Medical device (8694)
Medtech (8848)
Mergers & acquisitions (14490)
Metabolic disorders (725)
mRNA (64)
Multiple sclerosis (105)
NASH (4)
Neurodegenerative disease (230)
Neuropsychiatric disorders (42)
Neuroscience (1879)
NextGen: Class of 2026 (3175)
Non-profit (863)
Now hiring (7)
Obesity (230)
Opinion (17)
Ovarian cancer (162)
Pain (177)
Pancreatic cancer (209)
Parkinson's disease (205)
Partnered (12)
Patents (491)
Patient recruitment (543)
Peanut (31)
People (41526)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15639)
Phase 2 (21535)
Phase 3 (14566)
Pipeline (7705)
Policy (20)
Postmarket research (1574)
Preclinical (6587)
Press Release (35)
Prostate cancer (241)
Psychedelics (7)
Radiopharmaceuticals (401)
Rare diseases (596)
Real estate (3042)
Recruiting (7)
Regulatory (15034)
Reports (22)
Research institute (594)
Resumes & cover letters (47)
Rett syndrome (42)
RNA editing (6)
RSV (48)
Schizophrenia (102)
Series A (163)
Series B (125)
Service/supplier (5)
Sickle cell disease (63)
Special edition (2)
Spinal muscular atrophy (89)
Sponsored (7)
Startups (2041)
Stomach cancer (3)
Supply chain (57)
Tariffs (3)
The Weekly (5)
Vaccines (334)
Venture capital (20)
Weight loss (77)
Women's health (84)
Date
Today (115)
Last 7 days (377)
Last 30 days (1501)
Last 365 days (19386)
2026 (13451)
2025 (19554)
2024 (23214)
2023 (26754)
2022 (34776)
2021 (37317)
2020 (33567)
2019 (23368)
2018 (17545)
2017 (18828)
2016 (17976)
2015 (24322)
2014 (21734)
2013 (18191)
2012 (20270)
2011 (20487)
2010 (20377)
Location
Africa (231)
Alabama (75)
Alaska (2)
Arizona (308)
Arkansas (11)
Asia (18061)
Australia (2391)
California (12285)
Canada (3209)
China (564)
Colorado (490)
Connecticut (425)
Delaware (214)
Europe (25398)
Florida (1840)
Georgia (391)
Hawaii (3)
Idaho (46)
Illinois (721)
India (53)
Indiana (382)
Iowa (16)
Japan (416)
Kansas (101)
Kentucky (31)
Louisiana (27)
Maine (26)
Maryland (1221)
Massachusetts (8114)
Michigan (314)
Minnesota (569)
Mississippi (4)
Missouri (86)
Montana (20)
Nebraska (11)
Nevada (119)
New Hampshire (60)
New Jersey (2682)
New Mexico (12)
New York (2876)
North Carolina (1305)
North Dakota (4)
Northern California (6172)
Ohio (288)
Oklahoma (14)
Oregon (16)
Pennsylvania (2294)
Puerto Rico (20)
Rhode Island (30)
South America (410)
South Carolina (77)
South Dakota (1)
Southern California (5106)
Tennessee (124)
Texas (1990)
United States (39929)
Utah (367)
Vermont (1)
Virginia (157)
Washington D.C. (38)
Washington State (955)
West Virginia (1)
Wisconsin (91)
Wyoming (1)
487,774 Results for "avid radiopharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Neurodegenerative disease
Novartis’ $12B Avidity buy pays dividends with Phase 1/2 muscular dystrophy win
The RNA-based medicine is one of a handful of antibody-oligonucleotide conjugates that Novartis acquired last October when it took over neuromuscular-focused Avidity Biosciences.
June 12, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Defence Therapeutics Strengthens Radiopharmaceutical Leadership with Appointment of Dr. Ryan Simms as Chief Operating Officer and Head of Radiopharmaceutical Programs
August 17, 2026
·
4 min read
Neuroscience
Novartis’ $12B Avidity acquisition hits Phase 3 speedbump as dystrophy drug disappoints
While Novartis’ antibody-oligonucleotide conjugate failed to significantly improve hand function in patients with myotonic dystrophy type 1, the asset nevertheless showed signs of clinical activity in secondary and exploratory measures.
September 8, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Champions Oncology Expands Integrated Radiopharmaceutical Development Platform with In-House SPECT/CT Imaging
September 1, 2026
·
3 min read
Press Releases
Defence Therapeutics Expands Radiopharmaceutical Development Strategy with Alpha and Beta-Emitter Programs
August 31, 2026
·
4 min read
Press Releases
Ratio Therapeutics Enters into Research Collaboration and License Agreement with RayzeBio to Advance a Novel Radiopharmaceutical Program
September 9, 2026
·
3 min read
Press Releases
Archeus Technologies Reconstitutes Advisory Board to Advance Clinical-Stage Radiopharmaceutical Pipeline
August 4, 2026
·
5 min read
Press Releases
Molecular Targeting Technologies Receives Pharma Tech Outlook’s 2026 “Radiopharmaceutical Therapy Solution of the Year” Award for EvaThera™
September 1, 2026
·
9 min read
Press Releases
AtomVie Global Radiopharma Celebrates the Grand Opening of its New State-of-the-Art Radiopharmaceutical Manufacturing Facility in Hamilton, Ontario
September 6, 2026
·
3 min read
Press Releases
Starget Pharma Expands Scientific Advisory Board with Appointment of Two Global Leaders in Radiopharmaceutical Therapy
July 28, 2026
·
3 min read
1 of 48,778
Next
